US Patent Issued to Wuxi Biocity Biopharmaceutics on Nov. 25 for "Crystalline form of ATR inhibitor and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,479,839, issued on Nov. 25, was assigned to Wuxi Biocity Biopharmaceutics Co. Ltd. (Jiangsu, China).

"Crystalline form of ATR inhibitor and use thereof" was invented by Jian Wang (Shanghai), Ting Yao (Shanghai), Wenyuan Qian (Shanghai), Jian Li (Shanghai) and Shuhui Chen (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Crystalline forms of an ATR inhibitor, preparation methods therefor, and the use thereof in the preparation of a drug for treating ATR-related diseases. In particular, crystalline forms of an ATR inhibitor represented by formula (I), physicochemical and biochemical properties of the same, preparation methods for, and uses of the s...